Related references
Note: Only part of the references are listed.BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Thomas Reithmeier et al.
BMC CANCER (2010)
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
James R. Perry et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme Clinical article
Tomokazu Aoki et al.
JOURNAL OF NEUROSURGERY (2010)
Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring Clinical article
Guenther C. Feigl et al.
JOURNAL OF NEUROSURGERY (2010)
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Philip C. De Witt Hamer
NEURO-ONCOLOGY (2010)
Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Neurological outcome of long-term glioblastoma survivors
Andreas F. Hottinger et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
M. Glas et al.
ONCOLOGY (2009)
Analysis of EGFR Gene Amplification, Protein Over-expression and Tyrosine Kinase Domain Mutation in Recurrent Glioblastoma
Judit Toth et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Simultaneous Use of Functional Tractography, Neuronavigation-Integrated Subcortical White Matter Stimulation and Intraoperative Magnetic Resonance Imaging in Glioma Surgery: Technical Note
Jaime Gasco et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2009)
Mapping functional connectivity in patients with brain lesions
Adrian G. Guggisberg et al.
ANNALS OF NEUROLOGY (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery
Timothy C. Ryken et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia et al.
LANCET ONCOLOGY (2008)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
Graziella Filippini et al.
NEURO-ONCOLOGY (2008)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy
Ellen S. Mandl et al.
SURGICAL NEUROLOGY (2008)
Long-term survival with glioblastoma multiforme
Dietmar Krex et al.
BRAIN (2007)
Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme
Nicholas Butowski et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Accuracy of diffusion tensor magnetic resonance imaging tractography assessed using intraoperative subcortical stimulation mapping and magnetic source imaging
Jeffrey I. Berman et al.
JOURNAL OF NEUROSURGERY (2007)
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma
Antje Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma:: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
A. A. Brandes et al.
BRITISH JOURNAL OF CANCER (2006)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
PCV chemotherapy for recurrent glioblastoma
F Schmidt et al.
NEUROLOGY (2006)
Retrospective analysis of re-irradiation in malignant glioma:: a single-center experience
R Bartsch et al.
WIENER KLINISCHE WOCHENSCHRIFT (2005)
Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution
SE Combs et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy
AL Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme
A Mahajan et al.
JOURNAL OF NEUROSURGERY (2005)
Hypofractionated stereotactic re-irradiation:: Treatment option in recurrent malignant glioma -: art. no. 55
D Vordermark et al.
BMC CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
One week on/one week off:: A novel active regimen of temozolomide for recurrent glioblastoma
W Wick et al.
NEUROLOGY (2004)
Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: A single-institution retrospective study
M Kurimoto et al.
MINIMALLY INVASIVE NEUROSURGERY (2004)
Factors influencing survival in high-grade gliomas
JC Buckner
SEMINARS IN ONCOLOGY (2003)
Neuro-oncology working group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma
M Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
ER Laws et al.
JOURNAL OF NEUROSURGERY (2003)
Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy
G Voynov et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar et al.
RADIOLOGY (2000)
Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel
G Lederman et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
Share Paper
